CA
IDXX icon

Clearstead Advisors’s Idexx Laboratories IDXX Stock Holding History

Clearstead Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
2,307
+164
+8% +$92K 0.01% 502
2026
Q1 		$1.2M Sell
2,143
-731
-25% -$469K 0.01% 467
2025
Q4 		$1.94M Buy
2,874
+556
+24% +$379K 0.02% 335
2025
Q3 		$1.48M Buy
2,318
+90
+4% +$54.6K 0.02% 368
2025
Q2 		$1.19M Buy
2,228
+341
+18% +$163K 0.02% 403
2025
Q1 		$792K Buy
1,887
+158
+9% +$68.6K 0.01% 463
2024
Q4 		$715K Buy
1,729
+20
+1% +$8.77K 0.01% 484
2024
Q3 		$863K Buy
1,709
+8
+0.5% +$3.89K 0.01% 445
2024
Q2 		$829K Buy
1,701
+1,587
+1,392% +$797K 0.01% 430
2024
Q1 		$57.3K Sell
114
-5
-4% -$2.73K ﹤0.01% 731
2023
Q4 		$66.1K Buy
119
+5
+4% +$2.35K ﹤0.01% 680
2023
Q3 		$49.8K Hold
114
– – ﹤0.01% 704
2023
Q2 		$57.3K Hold
114
– – ﹤0.01% 709
2023
Q1 		$57K Buy
114
+104
+1,040% +$49.8K ﹤0.01% 636
2022
Q4 		$4.08K Hold
10
– – ﹤0.01% 1005
2022
Q3 		$3K Sell
10
-1,511
-99% -$555K ﹤0.01% 1032
2022
Q2 		$533K Buy
1,521
+6
+0.4% +$2.45K 0.04% 239
2022
Q1 		$829K Sell
1,515
-194
-11% -$102K 0.06% 200
2021
Q4 		$1.13M Hold
1,709
– – 0.08% 172
2021
Q3 		$1.06M Sell
1,709
-8
-0.5% -$5.38K 0.08% 165
2021
Q2 		$1.08M Sell
1,717
-12
-0.7% -$6.63K 0.08% 161
2021
Q1 		$846K Buy
1,729
+25
+1% +$12.5K 0.07% 174
2020
Q4 		$852K Buy
+1,704
New +$762K 0.08% 163

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clearstead Advisors's IDXX Position: Q2 2026 in Review

Clearstead Advisors increased its Idexx Laboratories (IDXX) stake by 7.7% in Q2 2026, buying an estimated $92K and bringing the position to 2,307 shares worth $1.21M. The position accounts for 0.01% of the portfolio, ranked #502.

Clearstead Advisors first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.94M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clearstead Advisors held 2,307 shares of Idexx Laboratories worth $1.21M as of Q2 2026.
  • Clearstead Advisors bought 164 Idexx Laboratories shares in Q2 2026, an estimated $92K.
  • Idexx Laboratories made up 0.01% of Clearstead Advisors's portfolio in Q2 2026, its #502 holding.
  • Clearstead Advisors first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Clearstead Advisors's Idexx Laboratories position peaked at $1.94M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.